Addus HomeCare (ADUS) Stock Overview
Provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
ADUS Community Fair Values
Create NarrativeSee what 70 others think this stock is worth. Follow their fair value or set your own to get alerts.
Addus HomeCare Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$113.80 |
| 52 Week High | US$124.44 |
| 52 Week Low | US$88.96 |
| Beta | 0.92 |
| 1 Month Change | 5.86% |
| 3 Month Change | 4.40% |
| 1 Year Change | 0.14% |
| 3 Year Change | 8.01% |
| 5 Year Change | -1.12% |
| Change since IPO | 1,240.40% |
Recent News & Updates
Recent updates
Does Addus HomeCare (NASDAQ:ADUS) Have A Healthy Balance Sheet?
Nov 01
Do Addus HomeCare's (NASDAQ:ADUS) Earnings Warrant Your Attention?
Oct 06Weekly Picks: 🚖 A super-app quietly consolidating an entire region and 2 more picks
Sep 17
Quality at a Premium. A time to watch, not to buy?
Key Takeaways Consistent revenue growth, strong profitability, and a pristine balance sheet position Addus for sustained disciplined acquisitive growth and improved operational efficiency. The company's business model is resilient and defensive against cyclical downturns, making it a safe haven in times of economic uncertainty.Addus HomeCare: Decent Print, Weak Economics, Stay On Hold
Aug 12Is Addus HomeCare (NASDAQ:ADUS) Using Too Much Debt?
Jul 17At US$110, Is Addus HomeCare Corporation (NASDAQ:ADUS) Worth Looking At Closely?
Jul 03Are Investors Undervaluing Addus HomeCare Corporation (NASDAQ:ADUS) By 41%?
May 28Additional Considerations Required While Assessing Addus HomeCare's (NASDAQ:ADUS) Strong Earnings
May 14Addus HomeCare: A Cautious Hold
Apr 07Addus HomeCare (NASDAQ:ADUS) Has A Rock Solid Balance Sheet
Mar 13Addus HomeCare Corporation's (NASDAQ:ADUS) Stock Retreats 25% But Earnings Haven't Escaped The Attention Of Investors
Feb 26Addus HomeCare (NASDAQ:ADUS) Shareholders Will Want The ROCE Trajectory To Continue
Feb 25Is There Now An Opportunity In Addus HomeCare Corporation (NASDAQ:ADUS)?
Feb 12A Look At The Intrinsic Value Of Addus HomeCare Corporation (NASDAQ:ADUS)
Jan 29Addus HomeCare: Growth Capitalized At Higher Multiples
Dec 25Addus HomeCare (NASDAQ:ADUS) Ticks All The Boxes When It Comes To Earnings Growth
Dec 14When Should You Buy Addus HomeCare Corporation (NASDAQ:ADUS)?
Oct 31Addus HomeCare's (NASDAQ:ADUS) Returns On Capital Are Heading Higher
Oct 15A Look At The Fair Value Of Addus HomeCare Corporation (NASDAQ:ADUS)
Oct 02Some Confidence Is Lacking In Addus HomeCare Corporation's (NASDAQ:ADUS) P/E
Sep 18
Calculated Acquisitions And Financial Health Drive Positive Growth In Personal Care Market
Strategic financial management, including a successful stock offering and debt clearance, positions Addus HomeCare for growth and acquisitions, enhancing shareholder value.There May Be Underlying Issues With The Quality Of Addus HomeCare's (NASDAQ:ADUS) Earnings
Aug 14Is There Now An Opportunity In Addus HomeCare Corporation (NASDAQ:ADUS)?
Jul 14Addus HomeCare Corporation's (NASDAQ:ADUS) Share Price Could Signal Some Risk
Jun 13Addus HomeCare: Adding More Care
Jun 12Calculating The Fair Value Of Addus HomeCare Corporation (NASDAQ:ADUS)
Jun 01Here's Why We Think Addus HomeCare (NASDAQ:ADUS) Might Deserve Your Attention Today
May 08Is Addus HomeCare (NASDAQ:ADUS) Using Too Much Debt?
Apr 26At US$101, Is Addus HomeCare Corporation (NASDAQ:ADUS) Worth Looking At Closely?
Mar 22Investors Will Want Addus HomeCare's (NASDAQ:ADUS) Growth In ROCE To Persist
Feb 25Addus HomeCare Corporation's (NASDAQ:ADUS) P/E Still Appears To Be Reasonable
Feb 10Is Addus HomeCare (NASDAQ:ADUS) A Risky Investment?
Jan 15An Intrinsic Calculation For Addus HomeCare Corporation (NASDAQ:ADUS) Suggests It's 27% Undervalued
Dec 30Addus HomeCare (NASDAQ:ADUS) Could Easily Take On More Debt
Oct 05At US$83.81, Is It Time To Put Addus HomeCare Corporation (NASDAQ:ADUS) On Your Watch List?
Sep 06Return Trends At Addus HomeCare (NASDAQ:ADUS) Aren't Appealing
Aug 18If EPS Growth Is Important To You, Addus HomeCare (NASDAQ:ADUS) Presents An Opportunity
Jul 06We Think Addus HomeCare (NASDAQ:ADUS) Can Manage Its Debt With Ease
Jun 03Returns On Capital At Addus HomeCare (NASDAQ:ADUS) Have Stalled
May 13Shareholder Returns
| ADUS | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 5.2% | 3.9% | -1.9% |
| 1Y | 0.1% | -18.4% | 10.9% |
Return vs Industry: ADUS exceeded the US Healthcare industry which returned -18.4% over the past year.
Return vs Market: ADUS underperformed the US Market which returned 10.9% over the past year.
Price Volatility
| ADUS volatility | |
|---|---|
| ADUS Average Weekly Movement | 3.9% |
| Healthcare Industry Average Movement | 6.9% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ADUS has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: ADUS's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | 27,934 | R. Allison | www.addus.com |
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living.
Addus HomeCare Corporation Fundamentals Summary
| ADUS fundamental statistics | |
|---|---|
| Market cap | US$2.08b |
| Earnings (TTM) | US$85.65m |
| Revenue (TTM) | US$1.35b |
Is ADUS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ADUS income statement (TTM) | |
|---|---|
| Revenue | US$1.35b |
| Cost of Revenue | US$906.85m |
| Gross Profit | US$439.75m |
| Other Expenses | US$354.10m |
| Earnings | US$85.65m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
Feb 23, 2026
| Earnings per share (EPS) | 4.70 |
| Gross Margin | 32.66% |
| Net Profit Margin | 6.36% |
| Debt/Equity Ratio | 14.3% |
How did ADUS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/17 20:43 |
| End of Day Share Price | 2026/02/13 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Addus HomeCare Corporation is covered by 22 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Matthew Gillmor | Baird |
| Andrew Mok | Barclays |
| Sean Dodge | BMO Capital Markets Equity Research |